Expand ACAD Menu

ACAD Stock Summary and Trading Ideas (Acadia Pharmaceuticals | NASDAQ:ACAD)

Charts for Today's Stock Price and Implied Volatility in Acadia Pharmaceuticals

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ACAD by Theoretical Edge and Win Rates



Trading Statistics

Key Ratios

Acadia Pharmaceuticals (ACAD) Frequently Asked Questions

What does Acadia Pharmaceuticals do?

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

What symbol and exchange does Acadia Pharmaceuticals stock trade?

Acadia Pharmaceuticals trades on the NASDAQ stock market under the symbol ACAD.

What is Acadia Pharmaceuticals stock price doing today?

As of June 25, 2024, ACAD stock price declined to $15.79 with 345,231 million shares trading.

What is Acadia Pharmaceuticals's Beta?

ACAD has a beta of 1.46, meaning it tends to be more sensitive to market movements. ACAD has a correlation of 0.09 to the broad based SPY ETF.

How much is Acadia Pharmaceuticals worth?

ACAD has a market cap of $2.61 billion. This is considered a Mid Cap stock.

How much money does Acadia Pharmaceuticals make?

Last quarter Acadia Pharmaceuticals reported $206 million in Revenue and $.10 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Acadia Pharmaceuticals traded in the last 3 year period?

In the last 3 years, ACAD stock traded as high as $33.99 and as low as $12.24.

What are the top ETFs holding Acadia Pharmaceuticals?

The top ETF exchange traded funds that ACAD belongs to (by Net Assets): VTI, VB, XBI, IWM, FBT.

Is Acadia Pharmaceuticals (ACAD) a good investment?

ACAD has underperformed the market in the last year with a return of -35.6%, while the SPY ETF gained +27.1%. In the last 3 month period, ACAD fell short of the market, returning -12.0%, while SPY returned +4.6%. However, in the most recent 2 weeks ACAD has outperformed the stock market by returning +6.1%, while SPY returned +1.8%.

What is the support and resistance for Acadia Pharmaceuticals (ACAD) stock price?

ACAD support price is $15.54 and resistance is $16.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACAD stock will trade within this expected range on the day.